Incretins and SGLT-2i Therapy of Type 2 Diabetes – Real Life Study of Their Therapeutic and Economic Effects

Incretins and SGLT-2i Therapy of Type 2 Diabetes – Real Life Study of Their Therapeutic and Economic Effects

AimIncretins [dipeptidyl peptidase-4 inhibitors (DPP-4i) and glucagon-like peptide 1 RA (GLP-1 RA)] and sodium-glucose cotransporter-2 inhibitors (SGLT-2i) groups are now routinely used for type 2 diabetes therapy and comprise a large number of medicinal products. The long term therapeutic and econo...

Full description

Bibliographic Details
Main Authors: Zornitsa Mitkova, Konstantin Mitov, Vasil Valov, Manoela Manova, Alexandra Savova, Maria Kamusheva, Dimitar Tcharaktchiev, Zhivko Angelov, Galia Angelova, Guenka Petrova
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-04-01
Series:Frontiers in Pharmacology
Subjects:
incretins
SGLT-inhibitors
diabetic incidents
HbA1c level
cost study
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2019.00364/full

Internet

https://www.frontiersin.org/article/10.3389/fphar.2019.00364/full

Similar Items